Fig. 1
From: Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis
Risk of disease progression at 12 months for IPF patients. Odds ratio from IPF patients divided into tertilesfrom baseline biomarker of C1M (A), PRO-C3 (B) and C3M (C) are shown for the middle and upper tertilecompared to the lowest tertile. Disease progression was defined as ≥ 5% decline in FVC and/or ≥ 10% decline in DLco or all-cause mortality at 12 months. Data are presented as mean and 95% CI (error bars) adjusted for age, sex, and baseline levels of FVC and DLco. Each tertilehad n = 59–60